Abstract
Ms. Sharpe is a 38-year-old high school administrator. She describes incapacitating headaches associated with vomiting that take her to bed. She reports having troublesome headaches two to three times a week, although she rarely misses work for headache. She does report that her family becomes angry with her for wanting to spend Friday evenings in bed rather than going to the movies or some other family activity. She has never found relief from analgesics or triptans. Her primary care physician (PCP) prescribes a nighttime dose of amitriptyline and arranges a follow-up visit in 3 weeks. Three weeks later, she reports no headache improvement and her PCP subsequently prescribes trials with propranolol, verapamil, and valproate, all without relief. At this point, Ms. Sharpe is given a daily headache-recording diary, which she is asked to keep over the next month. When the diary is reviewed, her PCP notes that, in addition to the one or two severe migraine episodes each week, she also records a daily headache that fluctuates in severity between mild and moderate, lasting most of the day. She also records daily use of four to six tablets of Excedrin per day, four ibuprofen tablets 3 days a week, and Imitrex twice a week. In her history, she also notes drinking approximately six cups of coffee daily. Because excessive use of analgesics, caffeinated products, and other acute care medications (e.g., triptans) typically aggravates underlying headache disorders, Ms. Sharpe’s PCP asks her to discontinue all acute therapies and limit coffee to two cups a day. She is also prescribed Relafen twice daily as treatment for rebound headache, and is allowed to take one additional Relafen dose on days with severe headache. One month later, she reports that she is no longer having daily headache, but still has a severe migraine once a week. This is easily managed with infrequent use of Imitrex, which had previously proven ineffective when taken in conjunction with daily analgesics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brett KM, Burt CW. Utilization of ambulatory medical care by women: United States, 1997–98. Vital Health Stat 2001; 13:1–46.
Gibbs TS, Fleischer AB, Feldman SR, Sam MC, O’Donovan CA. Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting. Headache 2003; 43:330–335.
Boardman HF, Thomas E, Croft PR, Millson DS. Epidemiology of headache in an English district. Cephalalgia 2003; 23:129–137.
Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991; 44:1147–1157.
Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001; 41:646–657.
Hasse LA, Ritchey N, Smith R. Predicting the number of headache visits by type of patient seen in family practice. Headache 2002; 42:738–746.
Tepper S, Newman L, Dowson A, et al. The prevalence and diagnosis of migraine in a primary care setting in the US: insights from the Landmark Study. Poster presented at 16th Annual Practicing Physician’s Approach to the Difficult Headache Patient; February 11–15, 2003; Rancho Mirage, CA.
Manzoni GC. Gender ratio of cluster headache over the years: a possible role of changes in lifestyle. Cephalalgia 1998; 18:138–142.
Delaney JS, Lacroix VJ, Gagne C, Antoniou J. Concussions among university football and soccer players: a pilot study. Clin J Sport Med 2001; 11:234–240.
Lance JC, Arciniegas DB. Post-traumatic headache. Curr Treat Options Neurol 2002; 4:89–104.
Packard RC. Posttraumatic headache: permanency and relationship to legal settlement. Headache 1992; 32:496–500.
Berglund A, Alfredsson L, Jensen I, Cassidy JD, Nygren A. The association between exposure to a rear-end collision and future health complaints. J Clin Epidemiol 2001; 54:851–856.
Kolbinson DA, Epstein JB, Burgess JA, Senthilselvan A. Temporomandibular disorders, headaches, and neck pain after motor vehicle accidents: a pilot investigation of persistence and litigation effects. J Prosthet Dent 1997; 77:46–53.
Kolbinson DA, Epstein JB, Burgess JA. Temporomandibular disorders, headaches, and neck pain following motor vehicle accidents and the effect of litigation: review of the literature. J Orofac Pain 1996; 10:101–125.
Mureriwa J. Head injury and compensation: a preliminary investigation of the postconcussional syndrome in Harare. Cent Afr J Med 1990; 36:315–318.
Gerth WC, Carides GW, Dasbach EJ, Visser WH, Santanello NC. The multinational impact of migraine symptoms on healthcare utilisation and work loss. Pharmacoeconomics 2001; 19:197–206.
Marcus DA. Identification of headache subjects at risk for psychological distress. Headache 2000; 40:373–376.
Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. J Occup Environ Med 1997; 39:320–327.
Marcus DA. Headache disability and headache diagnosis. Headache & Pain 2003; 14:180–185.
Lipton RB, Bigal ME, Kolodner K, et al. The family impact of migraine: population-based studies in the USA and UK. Cephalalgia 2003; 23:429–440.
Ramirez-Lassepas M, Espinosa CE, Cicero JJ, et al. Predictors of intracranial pathological findings in patients who seek emergency care because of headache. Arch Neurol 1997; 54:1506–1509.
Marcus DA: Migraine and tension headache: the questionable validity of current classification systems. Clin J Pain 1992; 8:28–36.
Rapoport AM, Weeks RE, Sheftell FD, Baskin SM, Verdi J. The “analgesic washout period”: a critical variable in the evaluation of treatment efficacy. Neurology 1986; 36(Suppl 1):100–101.
Mathew NT, Kailasam J, Gentry P, Chernyshev O. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial. Headache 2000; 40:464–465.
Krymchantowski AV, Barbosa JS. Rizatriptan combined with rofecoxib vs rizatriptan for the acute treatment of migraine: an open label pilot study. Cephalalgia 2002; 22:309–312.
Holroyd KA, France JL, Cordingley GE, et al. Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. J Consult Clin Psychol 1995; 63:327–330.
Marcus, DA: Sex hormones and chronic headache. Exp Opin Pharmacother 2001; 2:1839–1848.
Gintzler AR, Bohan MC. Pain thresholds are elevated during pseudopregnancy. Brain Res 1990; 507:312–316.
Sances G, Granella F, Nappi RE, et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003; 23:197–205.
Facchinetti F, Nappi RE, Granella F, et al. Effects of hormone replacement treatment (HRT) in postmenopausal women with migraine. Cephalalgia 2001; 21:452.
Marcus DA: Focus on primary care: diagnosis and management of headache in women. Obstetrical & Gynecological Survey 1999; 54:395–402.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
(2005). Headache. In: Marcus, D.A. (eds) Chronic Pain. Current Clinical Practice. Humana Press. https://doi.org/10.1385/1-59259-882-X:033
Download citation
DOI: https://doi.org/10.1385/1-59259-882-X:033
Publisher Name: Humana Press
Print ISBN: 978-1-58829-501-9
Online ISBN: 978-1-59259-882-3
eBook Packages: MedicineMedicine (R0)